The not-for profit Biological & Cellular GMP Manufacturing Facility is dedicated to facilitating phase I/II clinical development of innovative biologics through collaboration or contract with academic and corporate groups across the U.S.  The facility comprises of two sites for a total of 20 productions rooms and 20,000 sq. ft. of production space and 15,000 sq. ft. of development and analytical labs and support space.   In addition to cGMP manufacturing, we can provide up to 2000 vial semi-automated aseptic fill, process development and regulatory affairs expertise in all areas of cell and gene therapy, recombinant proteins, and synthetic molecules.

The Biological & Cellular GMP Manufacturing Facility staff has extensive biopharmaceutical expertise in the areas of cGMP manufacturing, regenerative medicine, viral and non-viral vector design, production and purification, monoclonal antibody production, chemical synthesis, drug discovery, regulatory affairs, quality assurance and process and product development.